On the public citation graph

Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza Neuraminidase Inhibitors

0 signed · 129 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1439-7633(20020301)3:2/3<246::aid-cbic246>3.0.co;2-#openalex-snapshot

pH‐Dependent Binding Modes Observed in Trypsin Crystals: Lessons for Structure‐Based Drug Design

inferredcites →https://doi.org/10.1002/9783906390406.ch14openalex-snapshot

CATALYST Pharmacophore Models and Their Utility As Queries for Searching 3D Databases

inferredcites →https://doi.org/10.1002/jcc.540160205openalex-snapshot

Poling: Promoting conformational variation

inferredcites →https://doi.org/10.1002/pro.5560031007openalex-snapshot

Influenza virus neuraminidase: Structure, antibodies, and inhibitors

inferredcites →https://doi.org/10.1002/prot.340060402openalex-snapshot

The neuraminidase of influenza virus

inferredcites →https://doi.org/10.1002/qsar.200390007openalex-snapshot

The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models

inferredcites →https://doi.org/10.1007/0-387-28146-0_17openalex-snapshot

The Structure, Function, and Inhibition of Influenza Virus Neuraminidase

inferredcites →https://doi.org/10.1007/s10719-006-5445-9openalex-snapshot

Unsaturated N-acetyl- D-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase

inferredcites →https://doi.org/10.1007/s10822-008-9240-5openalex-snapshot

On the interpretation and interpretability of quantitative structure–activity relationship models

inferredcites →https://doi.org/10.1016/0003-2697(79)90362-2openalex-snapshot

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrate

inferredcites →https://doi.org/10.1016/0223-5234(96)80447-8openalex-snapshot

Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-guanidino-Neu5Ac2en (GG167) with modified 5-substituents

inferredcites →https://doi.org/10.1016/j.bmc.2007.10.076openalex-snapshot

Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening

inferredcites →https://doi.org/10.1016/j.bmcl.2003.09.028openalex-snapshot

Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)

inferredcites →https://doi.org/10.1016/j.bmcl.2006.02.054openalex-snapshot

Neuraminidase pharmacophore model derived from diverse classes of inhibitors

inferredcites →https://doi.org/10.1016/j.drudis.2006.05.012openalex-snapshot

Virtual ligand screening: strategies, perspectives and limitations

inferredcites →https://doi.org/10.1016/j.ejmech.2004.10.014openalex-snapshot

Ligand-based assessment of factor Xa binding site flexibility via elaborate pharmacophore exploration and genetic algorithm-based QSAR modeling

inferredcites →https://doi.org/10.1016/j.jmb.2006.08.011openalex-snapshot

Expect the Unexpected or Caveat for Drug Designers: Multiple Structure Determinations Using Aldose Reductase Crystals Treated under Varying Soaking and Co-crystallisation Conditions

inferredcites →https://doi.org/10.1016/j.jmgm.2006.08.008openalex-snapshot

Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening

inferredcites →https://doi.org/10.1016/j.jmgm.2007.02.002openalex-snapshot

Combining docking, scoring and molecular field analyses to probe influenza neuraminidase–ligand interactions

inferredcites →https://doi.org/10.1016/j.micinf.2005.12.008openalex-snapshot

Roles of neuraminidase in the initial stage of influenza virus infection

inferredcites →https://doi.org/10.1016/j.sbi.2005.10.017openalex-snapshot

Enzymatic transition states and transition state analogues

inferredcites →https://doi.org/10.1016/j.str.2004.02.031openalex-snapshot

Heterogeneity and Inaccuracy in Protein Structures Solved by X-Ray Crystallography

inferredcites →https://doi.org/10.1016/s0040-4039(01)01605-7openalex-snapshot

Synthesis of (3 R *,4 R *)-4-acetylamino-3-(pent-3-oxy)cyclohex-1-ene-1-carboxylic acid and its (3 S* ,4 R* )-isomer and their inhibitory action against influenza virus sialidases

inferredcites →https://doi.org/10.1016/s0223-5234(00)80026-4openalex-snapshot

Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain

inferredcites →https://doi.org/10.1016/s0223-5234(99)80055-5openalex-snapshot

4-Acetylamino-3-(imidazol-1-yl)-benzoic acids as novel inhibitors of influenza sialidase

inferredcites →https://doi.org/10.1016/s0960-894x(00)00214-6openalex-snapshot

Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity

inferredcites →https://doi.org/10.1016/s0960-894x(01)00019-1openalex-snapshot

Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides

inferredcites →https://doi.org/10.1016/s0960-894x(02)00328-1openalex-snapshot

Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives

inferredcites →https://doi.org/10.1016/s0960-894x(02)00329-3openalex-snapshot

Synthesis and anti-Influenza virus activity of 7-O-Alkylated derivatives related to zanamivir

inferredcites →https://doi.org/10.1016/s0960-894x(02)01039-9openalex-snapshot

Synthesis and anti-influenza evaluation of orally active bicyclic ether derivatives related to zanamivir

inferredcites →https://doi.org/10.1016/s0960-894x(96)00542-2openalex-snapshot

Novel inhibitors of influenza sialidases related to GG167 structure-activity, crystallographic and Molecular dynamics studies with 4H-pyran-2-carboxylic acid 6-carboxamides

inferredcites →https://doi.org/10.1016/s0960-894x(97)00333-8openalex-snapshot

Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors

inferredcites →https://doi.org/10.1016/s0960-894x(97)00399-5openalex-snapshot

Novel inhibitors of influenza sialidases related to zanamivir. Heterocyclic replacements of the glycerol sidechain

inferredcites →https://doi.org/10.1016/s0960-894x(98)00587-3openalex-snapshot

A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity

inferredcites →https://doi.org/10.1016/s0968-0896(99)00197-2openalex-snapshot

Hydrophobic benzoic acids as inhibitors of influenza neuraminidase

inferredcites →https://doi.org/10.1016/s0969-2126(97)00265-7openalex-snapshot

‘Flu’ and structure-based drug design

inferredcites →https://doi.org/10.1016/s1093-3263(02)00164-xopenalex-snapshot

LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites

inferredcites →https://doi.org/10.1016/s1286-4579(02)00013-8openalex-snapshot

Pandemic influenza: its origin and control

inferredcites →https://doi.org/10.1016/s1359-6446(02)02411-xopenalex-snapshot

Why do we need so many chemical similarity search methods?

inferredcites →https://doi.org/10.1016/s1477-3627(02)02283-3openalex-snapshot

GPCRs: an update on structural approaches to drug discovery

inferredcites →https://doi.org/10.1021/ar0200495openalex-snapshot

Enzymatic Transition State Poise and Transition State Analogues

inferredcites →https://doi.org/10.1021/bi0205449openalex-snapshot

Influenza Neuraminidase Inhibitors: Structure-Based Design of a Novel Inhibitor Series

inferredcites →https://doi.org/10.1021/cb700228topenalex-snapshot

Rational Design of Transition-State Analogues as Potent Enzyme Inhibitors with Therapeutic Applications

inferredcites →https://doi.org/10.1021/ci00020a020openalex-snapshot

Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships

inferredcites →https://doi.org/10.1021/ci049844iopenalex-snapshot

Influenza Virus Neuraminidase Inhibitors: Generation and Comparison of Structure-Based and Common Feature Pharmacophore Hypotheses and Their Application in Virtual Screening

inferredcites →https://doi.org/10.1021/ci700130jopenalex-snapshot

A Comparison of Field-Based Similarity Searching Methods: CatShape, FBSS, and ROCS

inferredcites →https://doi.org/10.1021/ci960108ropenalex-snapshot

Three-Dimensional Shape-Based Searching of Conformationally Flexible Compounds

inferredcites →https://doi.org/10.1021/ja963036topenalex-snapshot

Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity

inferredcites →https://doi.org/10.1021/jm0002679openalex-snapshot

BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

inferredcites →https://doi.org/10.1021/jm010277popenalex-snapshot

Systematic Structure-Based Design and Stereoselective Synthesis of Novel Multisubstituted Cyclopentane Derivatives with Potent Antiinfluenza Activity

inferredcites →https://doi.org/10.1021/jm021032vopenalex-snapshot

Non-Peptide Angiotensin II Receptor Antagonists: Chemical Feature Based Pharmacophore Identification

inferredcites →https://doi.org/10.1021/jm049896zopenalex-snapshot

Pruned Receptor Surface Models and Pharmacophores for Three-Dimensional Database Searching

inferredcites →https://doi.org/10.1021/jm7009765openalex-snapshot

Pharmacophore Modeling, Quantitative Structure–Activity Relationship Analysis, and in Silico Screening Reveal Potent Glycogen Synthase Kinase-3β Inhibitory Activities for Cimetidine, Hydroxychloroquine, and Gemifloxacin

inferredcites →https://doi.org/10.1021/jm800718kopenalex-snapshot

Combining Ligand-Based Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis and in Silico Screening for the Discovery of New Potent Hormone Sensitive Lipase Inhibitors

inferredcites →https://doi.org/10.1021/jm970374bopenalex-snapshot

Dihydropyrancarboxamides Related to Zanamivir: A New Series of Inhibitors of Influenza Virus Sialidases. 1. Discovery, Synthesis, Biological Activity, and Structure−Activity Relationships of 4-Guanidino- and 4-Amino-4H-pyran-6-carboxamides

inferredcites →https://doi.org/10.1021/jm9703754openalex-snapshot

Dihydropyrancarboxamides Related to Zanamivir: A New Series of Inhibitors of Influenza Virus Sialidases. 2. Crystallographic and Molecular Modeling Study of Complexes of 4-Amino-4H-pyran-6-carboxamides and Sialidase from Influenza Virus Types A and B

inferredcites →https://doi.org/10.1021/jm970479eopenalex-snapshot

Design and Synthesis of Benzoic Acid Derivatives as Influenza Neuraminidase Inhibitors Using Structure-Based Drug Design

inferredcites →https://doi.org/10.1021/jm980162uopenalex-snapshot

Structure−Activity Relationship Studies of Novel Carbocyclic Influenza Neuraminidase Inhibitors

inferredcites →https://doi.org/10.1021/jm980707kopenalex-snapshot

Potent Inhibition of Influenza Sialidase by a Benzoic Acid Containing a 2-Pyrrolidinone Substituent

inferredcites →https://doi.org/10.1038/303041a0openalex-snapshot

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

inferredcites →https://doi.org/10.1038/363418a0openalex-snapshot

Rational design of potent sialidase-based inhibitors of influenza virus replication

inferredcites →https://doi.org/10.1038/4371108aopenalex-snapshot

Isolation of drug-resistant H5N1 virus

inferredcites →https://doi.org/10.1146/annurev.med.57.121304.131333openalex-snapshot

Avian Flu to Human Influenza

inferredcites →https://doi.org/10.1177/095632020201300401openalex-snapshot

New Millennium Antivirals against Pandemic and Epidemic Influenza: The Neuraminidase Inhibitors

inferredcites →https://doi.org/10.1517/13543784.6.10.1501openalex-snapshot

Sialidase as a target for inhibitors of influenza virus replication

inferredcites →https://doi.org/10.2174/1389450033491019openalex-snapshot

Recent Strategies in the Search for New Anti-Influenza Therapies

inferredcites →https://doi.org/10.3201/eid1201.051068openalex-snapshot

Vaccines and Antiviral Drugs in Pandemic Preparedness

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9783527633326.ch5openalex-snapshot

Pharmacophore Models for Virtual Screening

inferred← citeshttps://doi.org/10.1002/chem.71170openalex-snapshot

Pd‐Catalyzed Hydroalkoxycarbonylation and Hydroxycarbonylation: DFT Mapping of Catalyst‐Substrate Landscape for Product Selectivity

inferred← citeshttps://doi.org/10.1002/jcc.21635openalex-snapshot

Discovery of new β‐ D ‐galactosidase inhibitors via pharmacophore modeling and QSAR analysis followed by in silico screening

inferred← citeshttps://doi.org/10.1002/jmr.2604openalex-snapshot

Discovery of novel potent nuclear factor kappa‐B inhibitors (IKK‐β) via extensive ligand‐based modeling and virtual screening

inferred← citeshttps://doi.org/10.1002/jmr.2644openalex-snapshot

Computational modeling of the bat HKU4 coronavirus 3CLpro inhibitors as a tool for the development of antivirals against the emerging M iddle E ast respiratory syndrome ( MERS ) coronavirus

inferred← citeshttps://doi.org/10.1002/minf.202200049openalex-snapshot

Pharmacophore Modeling of Targets Infested with Activity Cliffs via Molecular Dynamics Simulation Coupled with QSAR and Comparison with other Pharmacophore Generation Methods: KDR as Case Study

inferred← citeshttps://doi.org/10.1002/minf.202300022openalex-snapshot

Augmenting bioactivity by docking‐generated multiple ligand poses to enhance machine learning and pharmacophore modelling: discovery of new TTK inhibitors as case study

inferred← citeshttps://doi.org/10.1007/978-1-60761-839-3_11openalex-snapshot

Pharmacophore-Based Virtual Screening

inferred← citeshttps://doi.org/10.1007/s00044-012-0204-xopenalex-snapshot

Ligand-based pharmacophore exploration and QSAR analysis of transition state analogues followed by in silico screening guide the discovery of new sub-micromolar β-secreatase inhibitors

inferred← citeshttps://doi.org/10.1007/s00044-014-0966-4openalex-snapshot

Elaborate ligand-based modeling reveals new human neutrophil elastase inhibitors

inferred← citeshttps://doi.org/10.1007/s00044-023-03057-3openalex-snapshot

Development of phosphoinositide 3-kinase delta (PI3Kδ) inhibitors as potential anticancer agents through the generation of ligand-based pharmacophores and biological screening

inferred← citeshttps://doi.org/10.1007/s00500-010-0598-7openalex-snapshot

Covariance matrix self-adaptation evolution strategies and other metaheuristic techniques for neural adaptive learning

inferred← citeshttps://doi.org/10.1007/s00894-010-0737-1openalex-snapshot

Discovery of new β-d-glucosidase inhibitors via pharmacophore modeling and QSAR analysis followed by in silico screening

inferred← citeshttps://doi.org/10.1007/s00894-014-2080-4openalex-snapshot

Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis

inferred← citeshttps://doi.org/10.1007/s10822-011-9509-yopenalex-snapshot

Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors

inferred← citeshttps://doi.org/10.1007/s10822-013-9699-6openalex-snapshot

Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors

inferred← citeshttps://doi.org/10.1007/s10822-015-9887-7openalex-snapshot

Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets

inferred← citeshttps://doi.org/10.1007/s10822-021-00435-0openalex-snapshot

Exploiting activity cliffs for building pharmacophore models and comparison with other pharmacophore generation methods: sphingosine kinase 1 as case study

inferred← citeshttps://doi.org/10.1007/s11030-024-10814-yopenalex-snapshot

Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes

inferred← citeshttps://doi.org/10.1007/s11696-026-05026-7openalex-snapshot

Discovery of potent VEGFR2 inhibitors as anticancer target, using pharmacophore based virtual screening, molecular docking and molecular dynamics simulation

inferred← citeshttps://doi.org/10.1007/s12247-026-10955-7openalex-snapshot

Decoding MLK4 Inhibition with Interpretable Machine Learning: Identification of a Novel Dihydroimidazopyridine-Based Promising Lead Compound

inferred← citeshttps://doi.org/10.1016/j.bmc.2010.03.043openalex-snapshot

Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent β-secretase inhibitory leads

inferred← citeshttps://doi.org/10.1016/j.cbi.2016.03.006openalex-snapshot

Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling

inferred← citeshttps://doi.org/10.1016/j.ejmech.2009.12.070openalex-snapshot

Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration

inferred← citeshttps://doi.org/10.1016/j.ejmech.2010.06.034openalex-snapshot

Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay

inferred← citeshttps://doi.org/10.1016/j.ejmech.2011.03.040openalex-snapshot

Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling

inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.07.056openalex-snapshot

Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis

inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.01.034openalex-snapshot

Ligand-based modeling of diverse aryalkylamines yields new potent P-glycoprotein inhibitors

inferred← citeshttps://doi.org/10.1016/j.jmgm.2011.02.001openalex-snapshot

Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation

inferred← citeshttps://doi.org/10.1016/j.jmgm.2012.04.001openalex-snapshot

Extensive ligand-based modeling and in silico screening reveal nanomolar inducible nitric oxide synthase (iNOS) inhibitors

inferred← citeshttps://doi.org/10.1016/j.jmgm.2013.03.003openalex-snapshot

Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitors

inferred← citeshttps://doi.org/10.1016/j.jmgm.2014.12.003openalex-snapshot

Ligand-based modeling followed by in vitro bioassay yielded new potent glucokinase activators

inferred← citeshttps://doi.org/10.1016/j.jmgm.2018.01.004openalex-snapshot

Ligand-based computer aided drug design reveals new tropomycin receptor kinase a (TrkA) inhibitors

inferred← citeshttps://doi.org/10.1016/j.jmgm.2018.02.001openalex-snapshot

Ligand-based modeling of Akt3 lead to potent dual Akt1/Akt3 inhibitor

inferred← citeshttps://doi.org/10.1016/j.jmgm.2019.01.011openalex-snapshot

Discovery of novel Flt3 inhibitory chemotypes through extensive ligand-based and new structure-based pharmacophore modelling methods

inferred← citeshttps://doi.org/10.1016/j.jmgm.2020.107615openalex-snapshot

Pharmacophore modeling of JAK1: A target infested with activity-cliffs

inferred← citeshttps://doi.org/10.1016/j.jmgm.2021.108022openalex-snapshot

QSAR-guided pharmacophoric modeling reveals important structural requirements for Polo kinase 1 (Plk1) inhibitors

inferred← citeshttps://doi.org/10.1021/acs.jcim.4c00720openalex-snapshot

SmartCADD: AI-QM Empowered Drug Discovery Platform with Explainability

inferred← citeshttps://doi.org/10.1021/acs.orglett.3c00498openalex-snapshot

Palladium-Catalyzed Hydroalkoxycarbonylation and Hydroxycarbonylation of Cyclopent-3-en-1-ols: Divergent Synthesis of Bridged Cyclic Lactones and β,γ-Unsaturated Carboxylic Acids

inferred← citeshttps://doi.org/10.1021/ci100222kopenalex-snapshot

Elaborate Ligand-Based Modeling Reveals New Nanomolar Heat Shock Protein 90α Inhibitors

inferred← citeshttps://doi.org/10.1021/ci100225bopenalex-snapshot

Correlation Analyses on Binding Affinity of Sialic Acid Analogues with Influenza Virus Neuraminidase-1 Using ab Initio MO Calculations on Their Complex Structures

inferred← citeshttps://doi.org/10.1021/ci100351sopenalex-snapshot

Development of Novel 3D-QSAR Combination Approach for Screening and Optimizing B-Raf Inhibitors in silico

inferred← citeshttps://doi.org/10.1021/co100019dopenalex-snapshot

Identifying Factors Controlling Protein Release from Combinatorial Biomaterial Libraries via Hybrid Data Mining Methods

inferred← citeshttps://doi.org/10.1039/c1np00053eopenalex-snapshot

Influenza neuraminidase: A druggable target for natural products

inferred← citeshttps://doi.org/10.1039/c2ob07015dopenalex-snapshot

A simple synthesis of N-perfluoroacylated and N-acylated glycals of neuraminic acid with a cyclic aminic substituent at the 4α position as possible inhibitors of sialidases

inferred← citeshttps://doi.org/10.1039/d2ra00136eopenalex-snapshot

Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning

inferred← citeshttps://doi.org/10.1080/07391102.2025.2507810openalex-snapshot

Pharmacophore modeling, 2D-QSAR, molecular docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA

inferred← citeshttps://doi.org/10.1109/bibmw.2010.5703855openalex-snapshot

Develop integration modeling approach for discovery neuraminidase inhibitors in silico based on pharmacophore and CoMSIA models

inferred← citeshttps://doi.org/10.1111/j.1747-0285.2011.01160.xopenalex-snapshot

Discovery of New Antifungal Leads via Pharmacophore Modeling and QSAR Analysis of Fungal N‐Myristoyl Transferase Inhibitors Followed by In Silico Screening

inferred← citeshttps://doi.org/10.1504/ijbra.2013.056076openalex-snapshot

Receptor-based pharmacophore tool for design and development of next-generation drugs

inferred← citeshttps://doi.org/10.1504/ijdmb.2014.060053openalex-snapshot

Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico

inferred← citeshttps://doi.org/10.1517/17460441.2014.909404openalex-snapshot

Advances in quantitative structure–activity relationship models of anti-Alzheimer’s agents

inferred← citeshttps://doi.org/10.2174/15701808113106660085openalex-snapshot

QSAR Study of H1N1 Neuraminidase Inhibitors from Influenza a Virus

inferred← citeshttps://doi.org/10.2174/1573406418666220118153541openalex-snapshot

Ligand-based Modeling of CXC Chemokine Receptor 4 and Identification of Inhibitors of Novel Chemotypes as Potential Leads towards New Anti- COVID-19 Treatments

inferred← citeshttps://doi.org/10.2174/1871520620666191224110600openalex-snapshot

Ligand Based Pharmacophore Modeling Followed by Biological Screening Lead to Discovery of Novel PDK1 Inhibitors as Anticancer Agents

inferred← citeshttps://doi.org/10.21767/2469-6692.10006openalex-snapshot

Discovery of Check Point Kinase 1 (Chk1) Inhibitors as Potential Anticancer Agents Using Ligand-Based Modelling and Virtual Screening

inferred← citeshttps://doi.org/10.3390/bioengineering12060622openalex-snapshot

Discovery of Novel Natural Inhibitors of H5N1 Neuraminidase Using Integrated Molecular Modeling and ADMET Prediction

inferred← citeshttps://doi.org/10.3390/life16040560openalex-snapshot

Arbutus andrachne Extracts Exhibit In Vitro Neuraminidase (N9) Inhibitory Activity: A Potential Herbal Strategy Against Avian Influenza

inferred← citeshttps://doi.org/10.4155/fmc-2015-0003openalex-snapshot

Innovative Computer-Aided Methods for the Discovery of New Kinase Ligands

inferred← citeshttps://doi.org/10.4155/fmc-2016-0056openalex-snapshot

Computer-Aided Discovery of New Fgfr-1 Inhibitors Followed by In Vitro Validation

inferred← citeshttps://doi.org/10.6026/97320630081139openalex-snapshot

Molecular modeling, docking and ADMET studies towards development of novel Disopyramide analogs for potential inhibition of human voltage gated sodium channel proteins

inferred← citeshttps://doi.org/10.7324/japs.2016.60907openalex-snapshot

The in Silico Study of Nutmeg Seeds (Myristica fragrans Houtt) as Peroxisome Proliferator Activated Receptor Gamma Activator Using 3D-QSAR Pharmacophore Modelling

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.